336 related articles for article (PubMed ID: 11923754)
41. Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease.
Varanasi RV; Fantry GT; Wilson KT
Helicobacter; 1998 Sep; 3(3):188-94. PubMed ID: 9731990
[TBL] [Abstract][Full Text] [Related]
42. Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: the systematic investigation of gastrointestinal diseases in China (SILC).
Zou D; He J; Ma X; Chen J; Gong Y; Man X; Gao L; Wang R; Zhao Y; Yan X; Liu W; Wernersson B; Johansson S; Dent J; Sung JJ; Li Z
Scand J Gastroenterol; 2011 Feb; 46(2):133-41. PubMed ID: 20955088
[TBL] [Abstract][Full Text] [Related]
43. [Diagnosis of gastroesophageal reflux disease and dyspepsia].
Koop H
Praxis (Bern 1994); 2006 Aug; 95(31-32):1175-7. PubMed ID: 16909685
[TBL] [Abstract][Full Text] [Related]
44. Dyspepsia: current understanding and management.
Agréus L; Talley NJ
Annu Rev Med; 1998; 49():475-93. PubMed ID: 9509276
[TBL] [Abstract][Full Text] [Related]
45. Gastroesophageal reflux disease and Helicobacter pylori infection.
Vakil N
Rev Gastroenterol Disord; 2003; 3(1):1-7. PubMed ID: 12684588
[TBL] [Abstract][Full Text] [Related]
46. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan.
Fujiwara Y; Higuchi K; Shiba M; Yamamori K; Watanabe Y; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Am J Gastroenterol; 2005 Apr; 100(4):754-8. PubMed ID: 15784015
[TBL] [Abstract][Full Text] [Related]
47. Helicobacter pylori and non-malignant diseases.
Rokkas T; Simsek I; Ladas S
Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
[TBL] [Abstract][Full Text] [Related]
48. The role of Helicobacter pylori in esophagitis and peptic ulcer disease in Iraq.
Al-Saadi AM; Al-Khayat JQ; Muhammad IM; Anwar SA
Saudi Med J; 2004 Sep; 25(9):1216-22. PubMed ID: 15448769
[TBL] [Abstract][Full Text] [Related]
49. Comparison of helisal rapid blood test and 14C-urea breath test in determining Helicobacter pylori status and predicting ulcer disease in dyspeptic patients.
Mowat C; Murray L; Hilditch TE; Kelman A; Oien K; McColl KE
Am J Gastroenterol; 1998 Jan; 93(1):20-5. PubMed ID: 9448167
[TBL] [Abstract][Full Text] [Related]
50. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
51. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
Kearney DJ; Liu CF; Crump C; Brousal A
Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
[TBL] [Abstract][Full Text] [Related]
52. Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis.
Wu JC; Cheung CM; Wong VW; Sung JJ
Clin Gastroenterol Hepatol; 2007 Jun; 5(6):690-5. PubMed ID: 17481961
[TBL] [Abstract][Full Text] [Related]
53. The association between helicobacter pylori infection and erosive gastroesophageal reflux disease; a cross-sectional study.
Niknam R; Lankarani KB; Moghadami M; Taghavi SA; Zahiri L; Fallahi MJ
BMC Infect Dis; 2022 Mar; 22(1):267. PubMed ID: 35305563
[TBL] [Abstract][Full Text] [Related]
54. Epidemiology of Helicobacter pylori and peptic ulcer in India.
Singh V; Trikha B; Nain CK; Singh K; Vaiphei K
J Gastroenterol Hepatol; 2002 Jun; 17(6):659-65. PubMed ID: 12100610
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of esophagitis in H. pylori-positive peptic ulcer disease and the impact of eradication therapy.
O'Connor HJ; McGee C; Ghabash NM; Cunnane K
Hepatogastroenterology; 2001; 48(40):1064-8. PubMed ID: 11490801
[TBL] [Abstract][Full Text] [Related]
56. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study.
Thomson AB; Barkun AN; Armstrong D; Chiba N; White RJ; Daniels S; Escobedo S; Chakraborty B; Sinclair P; Van Zanten SJ
Aliment Pharmacol Ther; 2003 Jun; 17(12):1481-91. PubMed ID: 12823150
[TBL] [Abstract][Full Text] [Related]
57. Incidence of Helicobacter pylori infection in Ghanaian patients with dyspeptic symptoms referred for upper gastrointestinal endoscopy.
Baako BN; Darko R
West Afr J Med; 1996; 15(4):223-7. PubMed ID: 9020601
[TBL] [Abstract][Full Text] [Related]
58. Helicobacter pylori infection and nonmalignant diseases.
de Vries AC; Kuipers EJ
Helicobacter; 2010 Sep; 15 Suppl 1():29-33. PubMed ID: 21054650
[TBL] [Abstract][Full Text] [Related]
59. Empiric treatment based on Helicobacter pylori serology cannot substitute for early endoscopy in the management of dyspeptic rural black Africans.
O'Keefe SJ; Salvador B; Nainkin J; Majiki S; Stevens H; Atherstone A
S Afr Med J; 2000 Nov; 90(11):1129-35. PubMed ID: 11196036
[TBL] [Abstract][Full Text] [Related]
60. Is there a relationship between Helicobacter pylori infection and erosive reflux disease in children?
Emiroglu HH; Sokucu S; Suoglu OD; Gulluoglu M; Gokce S
Acta Paediatr; 2010 Jan; 99(1):121-5. PubMed ID: 19785631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
